-
1
-
-
0015184521
-
-
(1) For example: (a) Lombardino, J. G; Wiseman, E. H.; Mclamore, W. M. J. Med. Chem. 1971, 14, 1171.
-
(1971)
J. Med. Chem.
, vol.14
, pp. 1171
-
-
Lombardino, J.G.1
Wiseman, E.H.2
Mclamore, W.M.3
-
2
-
-
84986492866
-
-
(b) Choi, S.-Y.; Lee, S.-G.; Yoon, Y.-J.; Kim, K.-W. J. Heterocyclic Chem. 1989, 26, 1073.
-
(1989)
J. Heterocyclic Chem.
, vol.26
, pp. 1073
-
-
Choi, S.-Y.1
Lee, S.-G.2
Yoon, Y.-J.3
Kim, K.-W.4
-
3
-
-
0023678961
-
-
(c) Sunkel, C. E.; de Casa-Juana, M. F.; Cillero, F. J.; Priego, J. G.; Ortega, M. P. J. Med. Chem. 1988, 31, 1886.
-
(1988)
J. Med. Chem.
, vol.31
, pp. 1886
-
-
Sunkel, C.E.1
De Casa-Juana, M.F.2
Cillero, F.J.3
Priego, J.G.4
Ortega, M.P.5
-
4
-
-
0029030350
-
-
(d) Nagasawa, H. T.; Kawle, S. P.; Elberling, J. A.; DeMaster, E. G.; Fukuto, J. M. J. Med. Chem. 1995, 38, 1865.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 1865
-
-
Nagasawa, H.T.1
Kawle, S.P.2
Elberling, J.A.3
DeMaster, E.G.4
Fukuto, J.M.5
-
5
-
-
0019158686
-
-
(e) Zimmerman, M.; Morman, H.; Mulvey, D.; Jones, H.; Frankshun, R.; Ashe, B. M. J. Bio. Chem. 1980, 255, 9848.
-
(1980)
J. Bio. Chem.
, vol.255
, pp. 9848
-
-
Zimmerman, M.1
Morman, H.2
Mulvey, D.3
Jones, H.4
Frankshun, R.5
Ashe, B.M.6
-
6
-
-
0028940903
-
-
and reference cited therein
-
(f) Silver, P. J.; Gordon, R. J.; Pagani, E. D.; Johnson, J. A.; Maycock, A. L.; Dunlap, R. P.; Ferguson, E. W.; Franke, C. A.; Drozd, M. L.; Robinson , D. T.; Eickhoff, W. M.; Baizman, E. R.; Subramanyam, C.; Desai, R. C.; Hlasta, D. J.; Newton, J. F. Drug Development Res. 1995, 34, 306 and reference cited therein.
-
(1995)
Drug Development Res.
, vol.34
, pp. 306
-
-
Silver, P.J.1
Gordon, R.J.2
Pagani, E.D.3
Johnson, J.A.4
Maycock, A.L.5
Dunlap, R.P.6
Ferguson, E.W.7
Franke, C.A.8
Drozd, M.L.9
Robinson, D.T.10
Eickhoff, W.M.11
Baizman, E.R.12
Subramanyam, C.13
Desai, R.C.14
Hlasta, D.J.15
Newton, J.F.16
-
7
-
-
0010607302
-
-
Patent, US 5,512,589 (Apr: 30, 1996)
-
(2) (a) Dunlap, R. P.; Boaz, N. W.; Mura, A. J.; Kumar, V.; Subramanyam, C.; Desai, R. C.; Hlasta, D. J.; Saindane, M. T.; Bell, M. R.; Court, J. J.; Farrell, R. P. Patent, US 5,512,589 (Apr: 30, 1996).
-
-
-
Dunlap, R.P.1
Boaz, N.W.2
Mura, A.J.3
Kumar, V.4
Subramanyam, C.5
Desai, R.C.6
Hlasta, D.J.7
Saindane, M.T.8
Bell, M.R.9
Court, J.J.10
Farrell, R.P.11
-
10
-
-
0024522096
-
-
(b) Abou-Gharbia, M.; Moyer, J. A.; Patel, U.; Webb, M.; Schiehser, G.; Andree, T.; Haskins, J. K. J. Med. Chem. 1989, 32, 1024.
-
(1989)
J. Med. Chem.
, vol.32
, pp. 1024
-
-
Abou-Gharbia, M.1
Moyer, J.A.2
Patel, U.3
Webb, M.4
Schiehser, G.5
Andree, T.6
Haskins, J.K.7
-
13
-
-
0010571023
-
-
note
-
(e) For related system using α,β-unsaturated hydrazones as dienes see
-
-
-
-
16
-
-
84980275934
-
-
(4) 2-(terf-Butyl)-isothiazolone-1,1-dioxide 2 was prepared from 3,3א-dithiodipropanoicacid according to literature procedures: (a) Lewis, S. N.; Millar, G. A.; Hausman, M.; Szamborski, E. C. J. Heterocyclic Chem. 1971, 8, 571.
-
(1971)
J. Heterocyclic Chem.
, vol.8
, pp. 571
-
-
Lewis, S.N.1
Millar, G.A.2
Hausman, M.3
Szamborski, E.C.4
-
17
-
-
84980311260
-
-
(b) Lewis, S. N.; Millar, G. A.; Hausman, M.; Szamborski, E. C. J. Heterocyclic Chem. 1971, 8, 591.
-
(1971)
J. Heterocyclic Chem.
, vol.8
, pp. 591
-
-
Lewis, S.N.1
Millar, G.A.2
Hausman, M.3
Szamborski, E.C.4
-
19
-
-
0010540393
-
-
note
-
1H NMR analysis on the crude reaction mixture indicated a 1.3:1 ratio of exo/endo products. Sometimes, a 2:1 ratio could be obtained. The reaction could not be carried out at high temperature due to the thermal instability of furfuryl alcohol.
-
-
-
-
20
-
-
0010572202
-
-
note
-
(6) For convenience, the numbering of benzisothiazolone-1,1-dioxide is used.
-
-
-
-
21
-
-
0010570726
-
-
note
-
tBu).
-
-
-
-
22
-
-
21144471734
-
-
(8) Ref. 3(d) and Burri, K. F. Chimia 1992, 46, 335.
-
(1992)
Chimia
, vol.46
, pp. 335
-
-
Burri, K.F.1
-
24
-
-
0010575938
-
-
note
-
(b) Atomic coordinates, thermal parameters, bond lengths and angles have been deposited with the Cambridge Crystallographic Data Center and can be obtained upon request.
-
-
-
-
25
-
-
6944251055
-
-
(10) Calculations were performed using Gaussian 94, Revision A.1, Gaussian, Inc., Pittsburgh PA, 1995. For a detailed discussion of this method, see: (a) Mller, C.; Plesset, M. S. Phys. Rev. 1934, 46, 618.
-
(1934)
Phys. Rev.
, vol.46
, pp. 618
-
-
Mller, C.1
Plesset, M.S.2
-
27
-
-
0002549529
-
-
(11) Houk, K. N.; Gonzalez, J.; Li, Y. Acct. Chem. Res. 1995, 28, 81.
-
(1995)
Acct. Chem. Res.
, vol.28
, pp. 81
-
-
Houk, K.N.1
Gonzalez, J.2
Li, Y.3
-
28
-
-
0010571024
-
-
note
-
(12) The reaction yield was reduced to 33% in the absence of TMSCl.
-
-
-
-
29
-
-
0010539577
-
-
note
-
(13) Presumably, dehydration of the endo isomer 4 under basic conditions involves unfavorable syn elimination, whereas favorable anti elimination takes place for the exo isomer 3.
-
-
-
|